# Chronicle: Session-2026-01-06-002

**Date:** 2026-01-06
**Session ID:** bd9ab246-07ec-4354-aff1-85a48f1acfbd
**Stop Reason:** prompt_input_exit
**Transcribed by:** Chronicle Capture Hook (Automated)

---

**User:**

Please read CLAUDE.md, notes from recent sessions, the idea tracker, and the workshop contents. Also review the previous session's chronicle entry. Lastly, read the Recursive Governance Loop document.

---

**Claude:**

I'll begin the session startup sequence by reading the required files.

---

**Claude:**

Session start checklist complete.

**Session ID:** `Session-2026-01-06-002`

---

## Context from Previous Session (2026-01-06-001)

**Major Accomplishments:**
1. **CR-013 CLOSED** — Implemented CAPA-3 (audit logging) and CAPA-4 (execution phase tracking)
2. **SOP-006 Draft Refined** — Streamlined to RS + RTM only (dropped DS, CS, OQ)
3. **CR-TEMPLATE Created** — With `{{template}}` vs `[execution]` placeholder distinction

**INV-003 CAPA Status:**

| CAPA | Description | Status |
|------|-------------|--------|
| CAPA-1a | Two-step identity verification in CLI | Not implemented |
| CAPA-1b | Identity enforcement in agent files | Not implemented |
| CAPA-1c | SOP-001 impersonation classification | Not implemented |
| CAPA-2 | CR template with execution placeholders | Workshop draft |
| CAPA-3 | Status transition logging | **CR-013 CLOSED** |
| CAPA-4 | Execution phase tracking | **CR-013 CLOSED** |

---

## SOP Landscape Summary

| SOP | Title | Status | Inconsistencies |
|-----|-------|--------|-----------------|
| SOP-001 | Document Control | EFFECTIVE | Lists DS, CS, OQ (stale) |
| SOP-002 | Change Control | EFFECTIVE | TP references need clarification |
| SOP-003 | Deviation Management | EFFECTIVE | Missing `revision_summary` |
| SOP-004 | Document Execution | EFFECTIVE | Missing `revision_summary` |
| SOP-005 | Code Governance | EFFECTIVE | DS references (stale) |
| SOP-006 | SDLC Governance | DRAFT | Workshop — awaiting CR |

**Cleanup path:** Per the session notes, staged CRs are recommended: formalize SOP-006 first, then update older SOPs to align.

---

## Workshop Contents

1. **SOP-006-SDLC-Governance-DRAFT.md** — Streamlined SDLC with RS + RTM only
2. **templates/CR-TEMPLATE.md** — CR template with execution-phase placeholders

---

## Idea Tracker Highlights

- **Identity verification architecture gap** (CRITICAL) — Agent identity via prompt injection only
- **SOP-007** — Security, User Management, Agent Orchestration
- **Execution instructions format** — Comments vs. visible content
- **Official templates under change control** — `QMS/TEMPLATE/` folder concept

---

## Git Status

Uncommitted changes:
- Updated chronicle INDEX
- Session-2026-01-06-001.md chronicle (new)
- `nul` (spurious Windows artifact)

---

How would you like to proceed?

---

**User:**

Let's look at the CR template together.

---

**Claude:**

Here's the CR template. Key structural elements:

**Two Frontmatter Blocks:**
- Lines 1-7: Template's own frontmatter (for when template becomes a governed document)
- Lines 22-25: Example frontmatter for actual CRs

**Two Placeholder Types:**
| Type | Syntax | When Replaced |
|------|--------|---------------|
| Template | `{{DOUBLE_CURLY}}` | During CR drafting |
| Execution | `[SQUARE_BRACKETS]` | During execution phase |

**Section Structure:**
1. Purpose
2. Scope (Context, Changes Summary, Files Affected)
3. Rationale
4. Implementation Plan
5. Testing Summary
6. Execution (table with EIs)
7. Execution Summary
8. Comments (table)
9. References

**Notable Features:**
- Execution phase instructions preserved in HTML comment (line 123-151)
- EI table has Status/Evidence/Follow-up columns
- Authors can define custom `[PLACEHOLDERS]` for their specific needs
- Comments table for execution-phase observations

**Open Question from Idea Tracker:**
> Should execution instructions be in HTML comments (invisible when rendered) or visible document content?

What aspects would you like to discuss or refine?

---

**User:**

This two-placeholder system is surprisingly powerful. It immediately suggests an application to test protocol-type documents, forms, etc.

---

**Claude:**

It is. The insight is that many documents have **two distinct authoring phases**:

| Phase | Actor | Fills | Document State |
|-------|-------|-------|----------------|
| **Design Time** | Author | `{{template}}` placeholders | DRAFT → PRE_APPROVED |
| **Run Time** | Executor | `[execution]` placeholders | IN_EXECUTION → CLOSED |

This maps cleanly to any "executable" document:

| Document Type | Design Time (Author) | Run Time (Executor) |
|---------------|---------------------|---------------------|
| **CR** | Scope, rationale, implementation plan | Evidence, status, follow-up |
| **TP** | Test steps, acceptance criteria, equipment | Actual results, pass/fail, timestamps |
| **Form** | Field labels, validation rules, instructions | Data entry, signatures |
| **Checklist** | Items to verify, expected conditions | Check marks, observations, initials |
| **INV** | Background, evidence gathered, root cause | CAPA completion status, closure evidence |

The pre-approval gate ensures the *structure* is reviewed before anyone fills in the *data*. That's the GMP principle: you can't execute a protocol that hasn't been approved.

**Potential template set:**

```
QMS/TEMPLATE/
├── CR-TEMPLATE.md      ← Have this
├── TP-TEMPLATE.md      ← Test Protocol
├── INV-TEMPLATE.md     ← Investigation
├── FORM-TEMPLATE.md    ← Generic form
└── CHECKLIST-TEMPLATE.md
```

Want to sketch out what a TP template might look like using this system?

---

**User:**

Yes, let's sketch out the TP template. The TP can be considered the most fundamental of the executable documents. At its core, a TP consists of (step, executable block) pairs. Have I mentioned to you what my job is, btw?

---

**Claude:**

You haven't mentioned your job in our sessions, at least not that I've seen in the chronicles or notes I've read. But your fluency with GMP concepts—stage gates, batch records, deviation management, the distinction between design-time and run-time documentation—suggests you have direct experience with regulated industries. Pharma? Medical devices? Biotech?

Feel free to share if relevant—it might inform how we shape these templates.

---

On the TP structure: yes, **(step, executable block)** as the atomic unit is elegant. It's the purest expression of the two-phase pattern:

```
┌─────────────────────────────────────────────────────────┐
│ STEP N: {{INSTRUCTION}}                                 │  ← Design time (author)
├─────────────────────────────────────────────────────────┤
│ Result: [RESULT]                                        │
│ Pass/Fail: [PASS_FAIL]                                  │  ← Run time (executor)
│ Executed by: [USER]  Date: [DATE]                       │
└─────────────────────────────────────────────────────────┘
```

Each step is self-contained: the instruction is locked after pre-approval, the execution fields are filled during the test run.

Should we start drafting the TP-TEMPLATE.md in the workshop?

---

**User:**

Yes, let's start drafting the TP template in the workshop. Actually, wait - let me back up. I know we want to guard against documentation proliferation, but at the same time, keeping our QMS aligned with the one I work with daily as an automation engineer in the pharmaceutical industry (Merck, in Durham, NC specifically) is also valuable. With that said, let's actually start with a TC template, where TC = Test Case. This, in fact, is more fundamental than a TP, because it doesn't have headers, footers, and other documentation fluff. It is very simple, and should be considered a type of "document fragment" or "free radical", if you will, since it wouldn't occur in isolation. It simply consists of a Prerequisite Section, a Test Script consisting of multiple (step, execution block) pairs, a Test Execution Comments box, and a Reviewer Comments box. The Prerequisite Section consists of a 2-row table (not including the headers) containing Test Case ID, Objectives, and Prerequisites. The row below that is a single merged cell for the Test Executor's signature.

---

**Claude:**

That context is valuable. Aligning with actual pharma QMS patterns—while keeping it lean—gives us a proven foundation.

The TC as a "document fragment" makes sense. It's the **atomic testable unit** that gets composed into TPs, OQs, or whatever higher-level structure is needed. No ceremony, just the essential structure.

Let me draft it:

---

**Claude:**

Draft created at `.claude/workshop/templates/TC-TEMPLATE.md`.

**Structure:**

```
TC-XXX: {{TITLE}}
│
├── Prerequisite Section
│   ├── [Test Case ID | Objectives | Prerequisites] table
│   └── [Executor Signature] merged row
│
├── Test Script
│   ├── Step 1: [Instruction | Expected Result]
│   │   └── Execution: [Actual Result | Pass/Fail | Executed By | Date]
│   ├── Step 2: ...
│   └── Step N: ...
│
├── Test Execution Comments (table)
│
└── Reviewer Comments (table)
```

**Design choices I made (open for discussion):**

1. Each step is a **table pair**—instruction table, then execution table. This visually separates design-time from run-time content.

2. Signature row is a single merged cell beneath the prerequisite table.

3. Separated Test Execution Comments from Reviewer Comments—different actors, different phases.

4. Noted in the header that TCs are fragments, not standalone documents.

Does this align with the Merck pattern, or should the step/execution block structure be different?

---

**User:**

We can streamline Merck's pattern a bit. The prerequisite section can be a single row, so that the Text Executor Signature is the final column.

---

**Claude:**

Cleaner. Single row with signature as the final column:

---

**Claude:**

Done. Prerequisite section is now a single row:

```
| Test Case ID | Objectives | Prerequisites | Test Executor Signature |
|--------------|------------|---------------|-------------------------|
| {{TC_ID}}    | {{OBJ}}    | {{PREREQS}}   | [EXECUTOR] — [DATE]     |
```

Three design-time fields, one execution-time field. Compact.

What about the step/execution block structure—does the two-table-per-step approach work, or should each step be a single table with more columns?

---

**User:**

The entire test script should be a multi-row table, with one row per step, and signature in the final column.

---

**Claude:**

Much cleaner—one table, all steps, signature per row:

---

**Claude:**

Done. Single table, clear left-to-right flow:

```
| Step | Instruction | Expected Result | Actual Result | Pass/Fail | Executed By — Date |
|------|-------------|-----------------|---------------|-----------|-------------------|
|  1   | {{...}}     | {{...}}         | [...]         | [P/F]     | [...] — [...]     |
|  2   | {{...}}     | {{...}}         | [...]         | [P/F]     | [...] — [...]     |
```

Design-time on the left (columns 1-3), run-time on the right (columns 4-6). The two-placeholder pattern is immediately visible in the column structure.

Any adjustments to the Comments sections, or does this capture the essential TC structure?

---

**User:**

The test script's "Step" column should not use a simple integer format, but should be in the format {{TEST_CASE_ID}}-001, {{TEST_CASE_ID}}-002, etc. Also, both comment rows should have Comment as the first column, followed by "Executed By - Date" for the Text Execution Comments and "Reviewed By - Date" for the Reviewer Comments box.

---

**Claude:**

Done. Updated structure:

**Test Script:**
```
| Step              | Instruction | Expected | Actual | P/F | Executed By — Date |
|-------------------|-------------|----------|--------|-----|-------------------|
| {{TC_ID}}-001     | {{...}}     | {{...}}  | [...]  |[P/F]| [...] — [...]     |
| {{TC_ID}}-002     | {{...}}     | {{...}}  | [...]  |[P/F]| [...] — [...]     |
```

**Test Execution Comments:**
```
| Comment   | Executed By — Date |
|-----------|-------------------|
| [COMMENT] | [EXECUTOR] — [DATE] |
```

**Reviewer Comments:**
```
| Comment   | Reviewed By — Date |
|-----------|-------------------|
| [COMMENT] | [REVIEWER] — [DATE] |
```

Step IDs now trace back to their parent TC. Comment tables are parallel in structure but distinguish executor from reviewer. Clean.

---

**User:**

For the Pass/Fail column, please actually write [Pass/Fail] instead of [P/F]. Also, please keep the "Test Execution Comments" wording, but in the signature columns, use the terminology "Performed By" instead of "Executed By". This is to potentially allow other signature types, like "Confirmed By" or "Witnessed By" or "Checked By" (which all have slightly different definitions, although I probably won't get into that much nuance in this QMS)

---

**Claude:**

Done. Updated:

**Test Script:**
```
| Step | Instruction | Expected Result | Actual Result | Pass/Fail | Performed By — Date |
```

**Test Execution Comments:**
```
| Comment | Performed By — Date |
```

"Performed By" is more flexible—it's the generic action. If you later need "Confirmed By" or "Witnessed By" variants, authors can substitute as needed while keeping the same structural pattern.

Should the Prerequisite Section signature also change from "Test Executor Signature" to something like "Performed By", or does it serve a different purpose there (overall TC sign-off vs. step-level signature)?

---

**User:**

Please used PERFORMER there as well

---

**Claude:**

Done. Consistent terminology throughout:

```
Prerequisite Section:  | ... | Performed By — Date |
Test Script:           | ... | Performed By — Date |
Test Execution Comments: | Comment | Performed By — Date |
Reviewer Comments:       | Comment | Reviewed By — Date |
```

All signature columns now use `[PERFORMER] — [DATE]` except Reviewer Comments which appropriately uses `[REVIEWER] — [DATE]`.

---

**User:**

Let's add some more boilerplate content. The reason I'm comfortable adding this wording is that is has proven to be an enduring (and therefore, probably valuable) fixture of Merck protocols. (1) Just below the prerequisite table, add "The signature above indicates that all listed test prerequisites have been satisfied and that the test script below is ready for execution." (2) Below that, write "Acceptance Criteria: The Actual Results match the Expected Results and all test steps are successfully executed with any exceptions resolved and appropriately addressed by tester and reviewer following the approved Exception Report (ER) workflow and applicable procedures."

---

**Claude:**

Done. Added the proven boilerplate:

```
| Test Case ID | Objectives | Prerequisites | Performed By — Date |
|--------------|------------|---------------|---------------------|
| {{TC_ID}}    | {{...}}    | {{...}}       | [PERFORMER] — [DATE] |

The signature above indicates that all listed test prerequisites have been 
satisfied and that the test script below is ready for execution.

**Acceptance Criteria:** The Actual Results match the Expected Results and 
all test steps are successfully executed with any exceptions resolved and 
appropriately addressed by tester and reviewer following the approved 
Exception Report (ER) workflow and applicable procedures.
```

Two key functions:
1. **Signature attestation** — Clarifies what the performer is affirming (prerequisites met, ready for execution)
2. **Acceptance criteria** — Establishes the pass/fail standard upfront, with explicit ER workflow reference for exceptions

This ties nicely back to SOP-004's scope integrity principle and the ER document type. Proven language that's survived regulatory scrutiny.

---

**User:**

Actually, please move the Acceptance Criteria statement to just above the Test Script table (but still under the Test Script section header)

---

**Claude:**

Done. Now the structure flows logically:

```
### Prerequisite Section
| ... | Performed By — Date |
The signature above indicates that all listed test prerequisites...

---

### Test Script
**Acceptance Criteria:** The Actual Results match the Expected Results...

| Step | Instruction | Expected Result | Actual Result | Pass/Fail | Performed By — Date |
```

Acceptance criteria now directly precedes the table it governs.

---

**User:**

I must admit that the official Merck statement for Acceptance Criteria is wordy. Can you rephrase it for clarity and conciseness? It can be split into more than one sentence if needed.

---

**Claude:**

No need to apologize—getting the tone right matters. Let me try a middle ground:

---

**Claude:**

How's this balance?

**Before (Merck original):**
> The Actual Results match the Expected Results and all test steps are successfully executed with any exceptions resolved and appropriately addressed by tester and reviewer following the approved Exception Report (ER) workflow and applicable procedures.

**After:**
> All test steps are executed and pass (Actual Results match Expected Results). Any exceptions must be resolved through the Exception Report (ER) workflow and reviewed by both tester and reviewer before the test case can be accepted.

Two sentences, same content, clearer structure.

---

**User:**

Above Acceptance Criteria, please write Instructions: Test execution must be performed in accordance with SOP-005 - Document Execution. The individual test steps must be executed in the order shown. If a test step fails, execution of the test script must pause. The executor of the test will explain what occured in the Actual Result field, mark the outcome of the step as "Fail", sign the step, and follow the ER workflow to document and remedy the testing failure.

---

**Claude:**

Done. I corrected the SOP reference—Document Execution is **SOP-004**, not SOP-005 (which is Code Governance).

Test Script section now has:

```
### Test Script

**Instructions:** Test execution must be performed in accordance with SOP-004 
Document Execution. The individual test steps must be executed in the order 
shown. If a test step fails, execution of the test script must pause. The 
executor of the test will explain what occurred in the Actual Result field, 
mark the outcome of the step as "Fail", sign the step, and follow the ER 
workflow to document and remedy the testing failure.

**Acceptance Criteria:** All test steps are executed and pass (Actual Results 
match Expected Results). Any exceptions must be resolved through the Exception 
Report (ER) workflow and reviewed by both tester and reviewer before the test 
case can be accepted.

| Step | Instruction | Expected Result | Actual Result | Pass/Fail | Performed By — Date |
```

Clear procedural flow: how to execute → what defines success → the execution table.

---

**User:**

Please add a note to the notes folder with the following provisional wording around test exceptions: An exception is a non-conformance encountered during execution or review of a test. All exceptions must be documented and resolved. If an exception occurs, the executor of the test must create an Exception Report (ER) and link it directly to the failed test step. For any test case, if the Actual Results do not match the Expected Results, the test case fails. This holds true even when the Actual Results are correct and the Expected Results are not correct. If the Actual Results match the Expected Results, but at the time of testing a problem is discovered with the system or the expected results, then the test step passes with exception. Any additional testing or re-resting performed as part of the exception process can be created within the ER as a new section. Before the ER is post-approved, all impacted documents must be verified as being revised and approved and required re-executions must be completed, reviewed, and approved with passing results.

---

**Claude:**

Created `.claude/notes/Session-2026-01-06-002/test-exception-concepts.md`

Structured the provisional wording into sections:

| Section | Key Point |
|---------|-----------|
| **Definition** | Exception = non-conformance during execution or review |
| **Workflow** | Create ER, link to failed step |
| **Actual ≠ Expected** | Fail (even if Actual is "correct" and Expected was wrong) |
| **Actual = Expected + problem found** | Pass with exception |
| **Re-testing** | Can be added as new section within ER |
| **ER Closure** | Impacted docs revised + re-executions passed before post-approval |

The "fail even when Actual is correct" rule is interesting—it enforces that the *protocol itself* must be fixed through proper change control rather than accepting ad-hoc "well, it worked" outcomes. Disciplined.

---

**User:**

Also add the following to the note, as provisional expanded Acceptance Criteria for test cases: Post-approval of this test case / protocol can not be performed until all of the following criteria have been met: (1) test cases have been successfully executed or have been appropriately addressed through the test exception process, including retesting if necessary. (2) supporting documentation is available, labeled, annotated, and properly cross-referenced, (3) exceptions, if applicable, have been closed, and (4) test casees have been signed by the test executor and reviewer.

---

**Claude:**

Added. The note now includes the four post-approval gates:

```
## Expanded Acceptance Criteria (Post-Approval Gate)

Post-approval cannot be performed until:

1. Test cases executed successfully (or addressed via exception process + retest)
2. Supporting documentation available, labeled, annotated, cross-referenced
3. Exceptions closed (if any)
4. Test cases signed by executor and reviewer
```

This parallels SOP-002 Section 7.3's post-review requirements but is specific to test execution. All four must be satisfied—no partial credit.

---

**User:**

Is the current version of our draft TC-TEMPLATE up-to-date?

---

**Claude:**

Yes, current and complete. Here's the structure:

```
TC-TEMPLATE.md
│
├── Frontmatter (template governance)
├── Template Document Notice (comment)
├── Template Usage Guide (comment)
│
├── ## {{TEST_CASE_ID}}: {{TEST_CASE_TITLE}}
│
├── ### Prerequisite Section
│   ├── Table: ID | Objectives | Prerequisites | Performed By — Date
│   └── Signature attestation statement
│
├── ### Test Script
│   ├── **Instructions:** (SOP-004 reference, sequential execution, failure handling)
│   ├── **Acceptance Criteria:** (pass definition, ER workflow reference)
│   └── Table: Step | Instruction | Expected | Actual | Pass/Fail | Performed By — Date
│
├── ### Test Execution Comments
│   └── Table: Comment | Performed By — Date
│
├── ### Reviewer Comments
│   └── Table: Comment | Reviewed By — Date
│
└── **END OF TEST CASE**
```

**Placeholder summary:**
- Design-time `{{...}}`: TEST_CASE_ID, TEST_CASE_TITLE, OBJECTIVES, PREREQUISITES, INSTRUCTION, EXPECTED
- Run-time `[...]`: PERFORMER, DATE, ACTUAL, Pass/Fail, COMMENT, REVIEWER

All changes from our discussion are incorporated. Ready for further refinement or to move on?

---

**User:**

Now sketch out the TP template wrapper

---

**Claude:**

Created `.claude/workshop/templates/TP-TEMPLATE.md`

**Structure:**

```
TP-TEMPLATE.md
│
├── Frontmatter (template governance)
├── Example frontmatter (for actual TPs)
├── Template Usage Guide
│
├── # {{TP_ID}}: {{TITLE}}
│
├── ## 1. Purpose
├── ## 2. Scope
│   ├── 2.1 System Under Test (system, version, commit)
│   ├── 2.2 Requirements Coverage (REQ_ID table)
│   └── 2.3 Out of Scope
├── ## 3. References
├── ## 4. Test Environment
│
├── ## 5. Protocol Approval (pre-execution signatures)
│   └── Author / Reviewer / Approver table
│
├── ## 6. Test Cases
│   ├── TC-001 (full TC structure embedded)
│   ├── TC-002 ...
│   └── (additional TCs)
│
├── ## 7. Protocol Summary
│   ├── 7.1 Test Case Results (rollup table)
│   ├── 7.2 Overall Result
│   └── 7.3 Execution Summary
│
├── ## 8. Protocol Closure (post-execution signatures)
│   └── Executor / Reviewer / Approver + attestation
│
└── **END OF TEST PROTOCOL**
```

**Key design decisions:**

1. **Section 5 vs Section 8** — Pre-execution approval (design time) vs post-execution closure (run time)
2. **TC embedding** — Full TC structure copied in, with instruction comment for adding more
3. **Section 7 rollup** — Aggregates TC results + overall pass/fail + narrative summary
4. **Closure attestation** — Uses the four criteria from our notes (executed, documented, exceptions closed, signed)

Thoughts on the wrapper structure?

---

**User:**

I have several comments. First, pre-approval signatures and post-approval signatures are handled by the QMS CLI, and do not need to be written into the body of the document itself. The exception to this rule: signatures that would be expected to occur as part of the actual execution of an executable document, i.e., test step Performed By signatures, Reviewed By signatures, etc. Also, I would prefer to handle document templates using a "nesting" approach. We have already specified the structure of TCs in the TC-TEMPLATE. Therefore, simply reference that template in the TP template, rather than recapitulating its contents. This allows updates to the TC template to automatically propagate to the TP template.

---

**Claude:**

Two excellent points:

1. **Workflow signatures vs execution signatures** — QMS CLI handles pre/post approval. Only *execution-phase* signatures belong in document body.

2. **Template nesting** — Reference TC-TEMPLATE rather than duplicate it. DRY principle.

---

**Claude:**

Revised. Much leaner:

```
TP-TEMPLATE.md
│
├── ## 1. Purpose
├── ## 2. Scope
│   ├── 2.1 System Under Test (table: system, version, commit)
│   ├── 2.2 Requirements Coverage (REQ_ID table)
│   └── 2.3 Out of Scope
├── ## 3. References (includes TC-TEMPLATE reference)
├── ## 4. Test Environment
│
├── ## 5. Test Cases
│   ├── TC-001 → "Insert per TC-TEMPLATE"
│   ├── TC-002 → "Insert per TC-TEMPLATE"
│   └── ...
│
└── ## 6. Protocol Summary
    ├── 6.1 Test Case Results (rollup table)
    ├── 6.2 Overall Result
    └── 6.3 Execution Summary
```

**Changes:**
- Removed Sections 5 & 8 (workflow signatures handled by QMS CLI)
- TC sections reference TC-TEMPLATE instead of duplicating content
- Added "Template Nesting" and "Workflow Signatures" notes in usage guide
- References section explicitly lists TC-TEMPLATE

The TP is now purely a wrapper—protocol-level context + TC placeholders + summary rollup.

---

**User:**

Please remove the Test Environment section and the Test Case Results section - the Overall Result and Execution Summary sections suffice. Also, References should always be at the end.

---

**Claude:**

Done. Final structure:

```
TP-TEMPLATE.md
│
├── ## 1. Purpose
├── ## 2. Scope
│   ├── 2.1 System Under Test
│   ├── 2.2 Requirements Coverage
│   └── 2.3 Out of Scope
├── ## 3. Test Cases
│   ├── TC-001 → per TC-TEMPLATE
│   └── TC-002 → per TC-TEMPLATE
├── ## 4. Protocol Summary
│   ├── 4.1 Overall Result
│   └── 4.2 Execution Summary
└── ## 5. References
```

Five sections. Clean wrapper around TC fragments.

---

**User:**

Please also remove the Out of Scope section. This must be common in pharma given that you included something Merck has in its documents, even without me telling you. But I've always found it annoying. The set of things out of scope includes almost the entire universe!

---

**Claude:**

Ha! Fair point. "Out of scope: everything else in the universe" isn't useful information.

---

**Claude:**

Done. Scope now contains only what matters:

```
## 2. Scope
├── 2.1 System Under Test
└── 2.2 Requirements Coverage
```

What *is* tested, not the infinite set of what isn't.

---

**User:**

The inclusion of a Requirements Coverage section is interesting. Merck does that, but not like this. Merck includes requirement IDs as a column in the actual test script. However, I opted not to incorporate that into the TC template for simplicity. But perhaps it would be warranted?

---

**Claude:**

Good question. Three options:

| Approach | Where REQ_ID Lives | Tradeoff |
|----------|-------------------|----------|
| **Protocol-level** (current) | TP Section 2.2 table | Simple TC, but no step→requirement link |
| **TC-level** | TC Prerequisite Section | Each TC states what it verifies |
| **Step-level** (Merck) | Test Script table column | Most granular, but adds column to every step |

**Argument for step-level:**
- Executor sees *why* they're performing each step
- Direct traceability: REQ-SIM-001 → TC-001-003
- RTM can be partially auto-generated from test scripts

**Argument against:**
- Adds column width to an already wide table
- Many steps may share the same REQ_ID (redundant)
- RTM already provides this mapping per SOP-006

**Middle ground option:**
- Keep TC template simple (no REQ_ID column)
- Add optional REQ_ID to TC Prerequisite Section: "This test case verifies: {{REQ_IDs}}"
- RTM provides the authoritative trace

What's your instinct? Step-level rigor, or keep TCs lean and let RTM carry the traceability?

---

**User:**

Let's add a REQ ID column to the TC template, and remove the Requirements Coverage section from the TP template.

---

**Claude:**

Done. 

**TC Test Script table now:**
```
| Step | REQ ID | Instruction | Expected Result | Actual Result | Pass/Fail | Performed By — Date |
|------|--------|-------------|-----------------|---------------|-----------|---------------------|
```
- Columns 1-4: Design-time
- Columns 5-7: Run-time

**TP Scope section now:**
```
## 2. Scope

| System | Version | Commit |
|--------|---------|--------|
```

Requirements traceability lives at the step level in TCs, not duplicated in TP header. Clean.

---

**User:**

Let's return to the TC template. We need to think about how we're going to deal with re-execution. It cannot overwrite the testing that failed.

---

**Claude:**

Critical point. The failed execution is evidence—it can't be erased.

**Options for re-execution:**

| Approach | Mechanism | Pros | Cons |
|----------|-----------|------|------|
| **Suffix rows** | Add TC-001-001-R1 below failed TC-001-001 | Keeps everything in one table, clear lineage | Table grows, multiple rows per logical step |
| **Re-execution section** | New section in TC after Test Script | Separates original from re-execution | Duplicates step structure |
| **Within ER** | Re-test documented in ER body | ER owns the exception end-to-end | Must cross-reference back to TC |
| **New TC** | TC-001-A for re-execution | Clean separation | Heavyweight, loses context |

**Your notes say:** "Any additional testing or re-testing performed as part of the exception process can be created within the ER as a new section."

**Question:** Should re-execution *always* live in the ER, or should the TC template also accommodate inline re-execution (suffix rows)?

The purist view: ER owns exceptions end-to-end, including re-test. TC shows original execution only.

The pragmatic view: Minor re-executions (after quick fix) might warrant suffix rows in TC to keep everything visible in one place.

Which direction?

---

**User:**

Let's go the purist route: ER owns the exception end-to-end, including retesting inside the ER. If an exception occurs in the ER, then there is an ER nested in the ER. This may sounds cumbersome but real-world experience shows it actually works and is conceptually quite sound, with not as much cognitive burden as you might expect.

---

**Claude:**

That's elegant. The recursive structure mirrors the QMS itself—exceptions handled by the exception mechanism, all the way down.

```
TC-001
├── Step TC-001-001: Fail
│   └── ER-001 (owns the exception)
│       ├── Documents failure
│       ├── Resolution
│       ├── Re-test (inside ER)
│       │   └── Step TC-001-001: Pass ✓
│       └── OR: Exception during re-test?
│           └── ER-001-ER-001 (nested)
│               ├── Documents new failure
│               ├── Resolution
│               └── Re-test
```

**TC stays clean:** Original execution only. Failed step remains as evidence.

**ER is self-contained:** Problem → resolution → re-test → closure (or escalation via nested ER).

Let me add this to the session notes:

---

**Claude:**

Documented. 

This elevates the ER template's importance—it needs to accommodate re-testing sections. Should we sketch out ER-TEMPLATE next, or continue refining TC/TP?

---

**User:**

Let's revisit the TC-TEMPLATE's Acceptance Criteria statement. Currently, it says "All test steps are executed and pass (Actual Results match Expected Results)." However, this is not the only acceptable condition - it is only the most straightforward condition. The other condition is that a test step has failed, with an ER attached to it containing retesting, and the ER is closed (indicating that the retesting was successful).

---

**Claude:**

Important edge case. Per the Instructions: "If a test step fails, execution must pause."

So steps 4-10 were never executed in the original run. Options:

| Marking | Meaning |
|---------|---------|
| **[Not Executed]** | Explicit—execution paused before this step |
| **N/A** | Ambiguous—could mean "not applicable" for other reasons |
| **Blank** | Leaves run-time fields empty |
| **[Blocked by TC-001-003]** | Explicit reference to the blocking step |

Then in the ER:
- Re-test step 3
- If step 3 passes, continue executing steps 4-10 *inside the ER*
- Or re-execute entire TC from step 1 inside ER (if fix was significant)

**Question:** Should steps 4-10 in the *original TC* be marked at all, or left with run-time placeholders intact? The ER would contain the complete successful execution record.

---

**User:**

Mark steps 4-10 as N/A with a reference to the ER in the Actual Results. The entire TC should be re-executed in the ER, since the re-testing could be written with different/more/fewer steps that wouldn't match one-to-one with the original. This is because one of the ways a test script could fail is because the test script was written poorly, not that there was something wrong with the system under test.

---

**Claude:**

That's a crucial insight—the test script itself might be the defect, not just the system. Re-execution must allow for a corrected test script.

So the pattern is:

**Original TC (failure at step 3):**
```
| Step | ... | Actual Result | Pass/Fail | Performed By |
|------|-----|---------------|-----------|--------------|
| TC-001-001 | ... | [result] | Pass | J. Smith — 2026-01-06 |
| TC-001-002 | ... | [result] | Pass | J. Smith — 2026-01-06 |
| TC-001-003 | ... | [what failed] | Fail | J. Smith — 2026-01-06 |
| TC-001-004 | ... | N/A — See ER-001 | N/A | J. Smith — 2026-01-06 |
| TC-001-005 | ... | N/A — See ER-001 | N/A | J. Smith — 2026-01-06 |
...
```

**ER-001 contains:**
- Full re-execution of TC (possibly revised test script)
- May have different steps than original
- Must pass for ER to close

Let me update the Acceptance Criteria and add to notes:

---

**Claude:**

Done. Updated both:

**TC Acceptance Criteria:**
> A test case is accepted when either: (1) all test steps pass (Actual Results match Expected Results), or (2) a step failed, subsequent steps are marked N/A with ER reference, and the ER contains a successful full re-execution of the test case and is closed.

**Session notes now document:**
- N/A marking pattern for subsequent steps
- Full re-execution rationale (test script itself may be defective)
- No assumption of one-to-one step correspondence

This also implies the ER template needs its own test script section—essentially embedding a TC structure for re-execution. The ER becomes a container for: problem description → resolution → re-test (full TC) → closure.

---

**User:**

Add to idea tracker: GMP conventions for signature and timestamp formats (i.e., lead 06Jan2025 05:24 PM)

---

**Claude:**

Added. The DDMmmYYYY format (06Jan2025) is smart—eliminates US/EU date ambiguity that plagues 01/06/2025 vs 06/01/2025.

---

**User:**

Add to that last idea: perhaps we should use UTC time if we want total unambiguity

---

**Claude:**

Done. UTC eliminates timezone ambiguity entirely—especially relevant for AI agents that don't have a "local" timezone.

---

**User:**

Sketch out the ER template now

---

**Claude:**

Created `.claude/workshop/templates/ER-TEMPLATE.md`

**Structure:**

```
ER-TEMPLATE.md
│
├── ## 1. Exception Identification
│   └── Table: Parent Doc | Failed Step | Executor | Date
│
├── ## 2. Problem Description
│
├── ## 3. Investigation
│   └── Root Cause
│
├── ## 4. Resolution
│   └── Table: Action | Description | Evidence
│
├── ## 5. Re-test
│   └── Full TC structure (per TC-TEMPLATE)
│       ├── Prerequisite Section
│       ├── Test Script (with nested ER guidance)
│       ├── Test Execution Comments
│       └── Reviewer Comments
│
├── ## 6. Closure Summary
│   ├── 6.1 Re-test Result
│   └── 6.2 Summary
│
└── ## 7. References
```

**Key design choices:**

1. **Section 5 embeds full TC structure** — not a reference, since re-test may differ from original
2. **Nested ER guidance** — Instructions note "create a nested ER" if re-test fails
3. **Resolution has Evidence column** — execution placeholder `[EVIDENCE]` for documenting fixes
4. **Closure Summary** — narrative tying together problem → resolution → re-test outcome

Thoughts?

---

**User:**

Let's strive for minimal information duplication: remove Executor and Date Identified from the Exception Identification section; this can inferred through the test step reference. The ID of an ER is: TC-ID-HERE-ER-001. Since the TC ID is of the format TP-ID-HERE-TC-001, then the full ER ID would be something like TP-ID-HERE-TC-001-ER-001. The initiated/created date of an ER would be automatically captured by the QMS. Each ER should have a Detailed Description, Root Cause, Exception Criticality, Proposed Corrective Action, and Exception Type. The above fields are locked after pre-approved of the ER. The editable fields of an ER are: the entire re-testing TC, followed by the ER Closure section, containing a single-row executable table, with columns Details of Resolution, Outcome, and Signature with Date.

---

**Claude:**

Done. Revised structure:

```
ER-TEMPLATE.md
│
├── ## 1. Exception Identification (locked)
│   └── Table: Parent Test Case | Failed Step
│
├── ## 2. Detailed Description (locked)
│
├── ## 3. Root Cause (locked)
│
├── ## 4. Exception Classification (locked)
│   └── Table: Criticality | Type
│
├── ## 5. Proposed Corrective Action (locked)
│
├── ## 6. Re-test (editable)
│   └── Full TC structure per TC-TEMPLATE
│
├── ## 7. ER Closure (editable)
│   └── Single-row table: Details of Resolution | Outcome | Performed By — Date
│
└── ## 8. References
```

**ID hierarchy:**
```
TP-001
└── TP-001-TC-001
    └── TP-001-TC-001-ER-001
        └── TP-001-TC-001-ER-001-ER-001 (nested)
```

**Locked vs Editable:**
- Sections 1-5: Locked after pre-approval (defines the exception)
- Sections 6-7: Editable during execution (re-test + closure)

Lean, no duplication, clear separation between problem definition and resolution execution.

---

**User:**

Actually, please get rid of the ER criticality. At Merck, this is used to distinguish between ERs that require re-execution, and ERs that don't. Since our QMS demands re-execution in all cases, we don't need to categorize ER criticality.

---

**Claude:**

Done. Simplified—no criticality distinction needed when re-execution is always required.

```
## 4. Exception Type

{{EXCEPTION_TYPE — e.g., Test Script Error, System Defect, Environmental, Documentation}}
```

---

**User:**

The Exception Type should be one of the following options: Test Script Error (test itself was written or designed incorrectly), Test Execution Error (tester made a mistake, i.e., by not following the instructions as written), System Error (the system under test behaved unexpectedly), Documentation Error (there is an error in a document other than the test script itself), or Other (no need to provide details, as the Detailed Description would cover this well enough.

---

**Claude:**

Done. Five defined types:

| Type | Meaning |
|------|---------|
| Test Script Error | Test itself was written or designed incorrectly |
| Test Execution Error | Tester made a mistake by not following instructions |
| System Error | System under test behaved unexpectedly |
| Documentation Error | Error in a document other than the test script |
| Other | See Detailed Description |

Clean taxonomy that covers the space without over-categorizing.

---

**User:**

In the ER-TEMPLATE TE-TEST INSTRUCTIONS, it says "The re-test may have different, more, or fewer steps than
the original if the test script itself required correction." Please follow this with a statement that if the test script itself is modified, it is the responsibility of the test script author and all reviewers to verify that the revised test script meets the intent of the original test script, as expressed in the original test script's objectives. If the TC objectives themselves are modified, this must be justified.

---

**Claude:**

Done. Added:

> If the test script is modified, the test script author and all reviewers must verify that the revised test script meets the intent of the original test script, as expressed in the original test script's objectives. If the TC objectives themselves are modified, this must be justified.

This ensures re-tests can't silently change what's being verified—the objectives anchor the intent.

---

**User:**

Please state somewhere, I'm not sure where, that the Test Execution Comments section (no matter where they occur, whether ERs, TCs, etc.) is the appropriate place to attach ERs that don't apply to any individual test step, but apply to the test script or protocol as a whole.

---

**Claude:**

Good clarification. This belongs in TC-TEMPLATE since that's where Test Execution Comments is defined (and ER inherits it via nesting):

---

**Claude:**

Done. Added to TC-TEMPLATE's Test Execution Comments:

> NOTE: This section is the appropriate place to attach ERs that do not apply to any individual test step, but apply to the test script or protocol as a whole (e.g., environmental issues, systemic problems discovered during testing).

Since TC structure is used in TPs and ER re-tests via nesting, this guidance propagates everywhere Test Execution Comments appears.

---

**User:**

Review all four templates side-by-side, and also compare to the content in test-exception-concenpts.md. Also compare to SOP-004. To what extent have we built a robust, internally consistent system?

---

**Claude:**

## Internal Consistency Analysis

### Strengths (Robust)

| Aspect | Finding |
|--------|---------|
| **Two-placeholder system** | Consistent across all 4 templates: `{{design-time}}` vs `[run-time]` |
| **Signature terminology** | "Performed By — Date" / "Reviewed By — Date" consistent in TC, TP, ER |
| **Template nesting** | TP → TC (reference), ER → TC (embedded for re-test flexibility) |
| **Locked vs Editable** | All templates clearly delineate pre-approved (locked) vs execution (editable) |
| **ER owns re-testing** | Consistent with test-exception-concepts.md design decision |
| **Nested ERs** | ER-TEMPLATE supports recursive structure per design decision |
| **N/A marking** | TC Acceptance Criteria matches test-exception-concepts.md (steps 4-10 → N/A with ER ref) |

### Gaps / Inconsistencies Found

| Issue | Location | Severity |
|-------|----------|----------|
| **1. CR comment table format differs** | CR: `Date \| User \| Comment` vs TC: `Comment \| Performed By — Date` | Minor |
| **2. CR status values differ from SOP-004** | CR adds PARTIAL, SKIPPED; omits IN_PROGRESS | Minor |
| **3. ER missing Impact Assessment** | SOP-004 §9.1 requires it; ER-TEMPLATE omits | **Medium** |
| **4. "Pass with exception" not in TC Acceptance Criteria** | test-exception-concepts.md defines it, TC doesn't mention | Medium |
| **5. ID hierarchy not in TC/TP** | Only documented in ER-TEMPLATE | Minor |
| **6. Post-approval gate (4 criteria) not in templates** | test-exception-concepts.md defines; templates don't reflect | Medium |

### Detailed Analysis

**Gap 3 — ER Impact Assessment:**
SOP-004 §9.1 requires:
> Issue description, **Impact assessment**, Resolution or disposition

ER-TEMPLATE has Detailed Description + Root Cause + Exception Type + Proposed Corrective Action, but no explicit Impact Assessment.

**Gap 4 — "Pass with Exception":**
test-exception-concepts.md says:
> If the Actual Results match the Expected Results, but at the time of testing a problem is discovered with the system or the expected results, then the test step passes with exception.

TC Acceptance Criteria only covers Pass or Fail-with-ER. This third scenario (Pass with exception) isn't captured.

**Gap 6 — Post-Approval Gate:**
test-exception-concepts.md lists 4 criteria for post-approval:
1. TCs executed or addressed via exception process
2. Supporting documentation available, labeled, annotated, cross-referenced
3. Exceptions closed
4. TCs signed by executor and reviewer

This isn't in TP-TEMPLATE's Protocol Summary or anywhere else.

### Recommendations

1. **Add Impact Assessment to ER-TEMPLATE** (Section 2.5 or merge with Detailed Description)
2. **Add "Pass with Exception" to TC Acceptance Criteria** or clarify it's handled via Test Execution Comments + ER
3. **Harmonize CR comment format** with TC pattern, or document the intentional difference
4. **Add post-approval gate to TP-TEMPLATE** Protocol Summary section
5. **Consider SOP-004 revision** to acknowledge test-specific terminology (TC, TP, ER structures)

### Verdict

**~85% internally consistent.** The core architecture is sound—two-placeholder system, template nesting, ER ownership of re-testing, recursive nesting. The gaps are addressable and mostly involve missing fields or documentation rather than conflicting rules.

Shall I address any of these gaps now?

---

**User:**

Gap 3 - We will update SOP-004 to remove the impact assessment requirement. Gap 4 - Let's skip this for now and handle this later if we actually codify this pass-with-exception scenario in SOP-004. As it stands, the step would simply be labeled Pass with no ER, since the TC instructions and SOP-004 don't say this scenario needs an ER. Am I right about that? Gap 6 - We need to update SOP-001, which handles document control, which would have closure of any documents, including test protocols, within its scope. Gap 1 - We need to update the CR comment table to match the TC comment table. Gap 2 - Can you elaborate? I don't understand what "status" you're referring to in the CR. Gap 5 - We should add the ID hierarchy to the TC and TP templates, possibly codify in an SOP later. Please summarize the plan to address the 6 identified issues. Please separate our approach into SOP-related changes and everything else. We will approach the SOP-related changes with a new CR.

---

**Claude:**

**Gap 2 Elaboration:**

The CR-TEMPLATE Section 6 execution table uses these status values:
```
PENDING, COMPLETE, PARTIAL, SKIPPED, BLOCKED
```

SOP-004 Section 7.1 defines these status values:
```
PENDING, IN_PROGRESS, COMPLETE, BLOCKED
```

Differences:
- CR-TEMPLATE adds: PARTIAL, SKIPPED
- CR-TEMPLATE omits: IN_PROGRESS

This is a minor inconsistency between the template and the governing SOP.

---

**Gap 4 Clarification:**

You're correct. Current TC Instructions say: "If a test step fails, execution of the test script must pause... and follow the ER workflow."

A step where Actual = Expected is a Pass—no ER triggered. If the tester discovers a problem while passing, they'd note it in Test Execution Comments (and potentially attach an ER there per our note about protocol-level ERs). But this isn't explicitly codified. We'll defer.

---

## Action Plan Summary

### SOP-Related Changes (New CR Required)

| Gap | SOP | Change |
|-----|-----|--------|
| 3 | SOP-004 §9.1 | Remove "Impact assessment" from ER content requirements |
| 6 | SOP-001 | Add post-approval gate (4 criteria) for executable document closure |
| 2 | SOP-004 §7.1 | Add PARTIAL, SKIPPED to status values (or remove from CR-TEMPLATE—your call) |

### Template Changes (Can Do Now)

| Gap | Template | Change |
|-----|----------|--------|
| 1 | CR-TEMPLATE | Update comment table from `Date \| User \| Comment` to `Comment \| Performed By — Date` |
| 5 | TC-TEMPLATE | Add ID hierarchy note (TC-NNN, TC-NNN-NNN for steps) |
| 5 | TP-TEMPLATE | Add ID hierarchy note (TP-NNN, TP-NNN-TC-NNN, step format) |

### Deferred

| Gap | Reason |
|-----|--------|
| 4 | Handle "pass with exception" if/when codified in SOP-004 |

---

Shall I proceed with the template changes now, and then we can draft the CR for SOP changes?

---

**User:**

Please create a document TO_DO_LIST.md in .claude/ and structure it like the idea tracker. First item: Handle the "pass with exception" issue.

---

**Claude:**

Created `.claude/TO_DO_LIST.md` with the first item.

Now shall I:
1. Proceed with the template changes (Gap 1 and Gap 5), then
2. Draft the CR for SOP changes (Gaps 2, 3, 6)?

---

**User:**

Next, please implement all of the template-related changes (no CR needed)

---

**Claude:**

Done. All template changes implemented:

**Gap 1 — CR-TEMPLATE comment table:**
```
Before: | Date | User | Comment |
After:  | Comment | Performed By — Date |
```

**Gap 5 — TC-TEMPLATE ID hierarchy added:**
```
ID HIERARCHY:
- Test Case ID: TC-NNN (within parent TP)
- Step ID: TC-NNN-NNN (e.g., TC-001-001, TC-001-002)
- ER ID: TC-NNN-ER-NNN (e.g., TC-001-ER-001)
- Nested ER ID: TC-NNN-ER-NNN-ER-NNN

Full hierarchy example:
  TP-001
  └── TP-001-TC-001
      ├── TP-001-TC-001-001 (step)
      ├── TP-001-TC-001-002 (step)
      └── TP-001-TC-001-ER-001 (exception)
          └── TP-001-TC-001-ER-001-ER-001 (nested exception)
```

**Gap 5 — TP-TEMPLATE ID hierarchy added:**
```
ID HIERARCHY:
- Protocol ID: TP-NNN
- Test Case ID: TP-NNN-TC-NNN (e.g., TP-001-TC-001)
- Step ID: TP-NNN-TC-NNN-NNN (e.g., TP-001-TC-001-001)
- ER ID: TP-NNN-TC-NNN-ER-NNN (e.g., TP-001-TC-001-ER-001)
- Nested ER: TP-NNN-TC-NNN-ER-NNN-ER-NNN
```

Ready to draft the CR for SOP changes (Gaps 2, 3, 6)?

---

**User:**

Let's discuss Gap 2 a bit further. We should treat the EI list in CRs more akin to test steps in protocols. In fact, I'm inclined to say they're basically isomorphic to test cases, if you think about it. The only difference would be that there might not be a need for a rigid, exact match between Expected Results and Actual Results. In fact, there should probably just be a "Task Description" (non-editable), "Task Outcome" (editable during execution), and a "Performed By - Date" column. Then, below that, the same two comment boxes as other places. In fact, something very much like an ER process could be used here if we want, when outcomes don't match the initial plan. What do you think?

---

**Claude:**

This is a compelling insight. Let me map the isomorphism:

| TC Test Step | CR Execution Item | Structural Role |
|--------------|-------------------|-----------------|
| Instruction | Task Description | What to do (static) |
| Expected Result | *Implicit: task completed as planned* | Success definition |
| Actual Result | Task Outcome | What happened (editable) |
| Pass/Fail | *Outcome matches plan or not* | Success/deviation |
| Performed By — Date | Performed By — Date | Accountability |
| Test Execution Comments | Execution Comments | Observations |
| Reviewer Comments | Reviewer Comments | Review feedback |
| ER on failure | ER on deviation | Exception handling |

The difference is **rigidity of success criteria:**
- TC: Actual must exactly match Expected → binary Pass/Fail
- CR: Outcome should align with plan → more qualitative assessment

But the **structure** is nearly identical:
1. Pre-approved scope (static)
2. Execution record (editable)
3. Signature
4. Comments
5. Exception handling when things don't go as planned

**Proposed CR EI table:**

```
| EI | Task Description | Task Outcome | Performed By — Date |
|----|------------------|--------------|---------------------|
| EI-1 | {{DESCRIPTION}} | [OUTCOME] | [PERFORMER] — [DATE] |
| EI-2 | {{DESCRIPTION}} | [OUTCOME] | [PERFORMER] — [DATE] |
```

Followed by:
- Execution Comments table
- Reviewer Comments table

**ER-like handling:** If an EI outcome deviates significantly from the plan, attach an ER (or CR-specific equivalent) explaining why, what was done instead, and sign off on the deviation.

This would:
- Harmonize CR and TC execution structure
- Remove the awkward Status/Evidence/Follow-up columns
- Make ER workflow available for CR execution deviations
- Align with the two-comment-box pattern

What's lost:
- Explicit Status values (PENDING, COMPLETE, BLOCKED, etc.)
- Separate Evidence column (could be incorporated into Task Outcome)

Do you want me to revise CR-TEMPLATE to this structure?

---

**User:**

In the CR EI table, please add a column between Task Description and Task Outcome called Execution Summary (editable during execution). It is for the narrative prose. The Task Outcome is the binary Pass/Fail.

---

**Claude:**

Now it's truly isomorphic:

| TC Column | CR Column | Type |
|-----------|-----------|------|
| Instruction | Task Description | Static |
| Actual Result | Execution Summary | Editable (narrative) |
| Pass/Fail | Task Outcome | Editable (binary) |
| Performed By — Date | Performed By — Date | Editable (signature) |

---

**Claude:**

Now I need to remove the old Section 8 Comments since the comment sections are now part of Section 6:

---

**Claude:**

Done. CR-TEMPLATE Section 6 now mirrors TC structure:

**EI Table:**
```
| EI | Task Description | Execution Summary | Task Outcome | Performed By — Date |
|----|------------------|-------------------|--------------|---------------------|
| EI-1 | {{DESCRIPTION}} | [SUMMARY] | [Pass/Fail] | [PERFORMER] — [DATE] |
```

**Comment Sections:**
- Execution Comments (with ER note for CR-level exceptions)
- Reviewer Comments

**Isomorphism complete:**

| TC | CR | Role |
|----|-----|------|
| Step | EI | Identifier |
| Instruction | Task Description | Static |
| Actual Result | Execution Summary | Narrative (editable) |
| Pass/Fail | Task Outcome | Binary (editable) |
| Performed By — Date | Performed By — Date | Signature |
| Test Execution Comments | Execution Comments | Observations |
| Reviewer Comments | Reviewer Comments | Review feedback |
| ER on failure | ER on failure | Exception handling |

**Updated CR structure:**
```
1. Purpose
2. Scope
3. Rationale
4. Implementation Plan
5. Testing Summary
6. Execution
   ├── EI Table
   ├── Execution Comments
   └── Reviewer Comments
7. Execution Summary
8. References
```

This eliminates the need for Gap 2's SOP change—the status values issue is resolved by replacing Status with Pass/Fail.

---

**User:**

I'm thinking that we can begin to think of ERs as "links" between executable documents. Currently, ERs are over-fit to act as links from TCs to other TCs. How much work would it be to generalize ERs to, for example, act as links from one CR or INV to another? Basically, an ER could be a general mechanism for encapsulating a blocking child action while not bogging down the parent document with all the potentially-messy details. The ability to nest ERs makes them very helpful as "deep containers"

---

**Claude:**

This is a powerful abstraction. ERs as **general-purpose blocking child containers** rather than TC-specific exception handlers.

**Current model (TC-centric):**
```
TC (parent)
└── ER (child) → contains re-test (TC structure)
    └── ER (grandchild) → contains re-test (TC structure)
```

**Generalized model:**
```
Any Executable Document (parent)
└── ER (child) → contains resolution work (flexible structure)
    └── ER (grandchild) → contains resolution work
```

**What changes:**

| Current (TC-specific) | Generalized | Change Scope |
|----------------------|-------------|--------------|
| Parent Test Case | Parent Document | Label only |
| Failed Step | Failed Item | Label only |
| Re-test section (TC structure) | Resolution Work (flexible) | Structure change |
| TC-NNN-ER-NNN | {DOC_ID}-ER-NNN | Already general |

**The key insight:** The Resolution Work section needs to be flexible:

| Parent Type | Resolution Work Might Be |
|-------------|-------------------------|
| TC | Re-test (TC structure) |
| CR | Task completion (EI table or narrative) |
| INV | CAPA execution (EI table or narrative) |
| TP | Protocol-level fix (narrative + evidence) |

**Proposed structure for generalized ER:**

```
1. Exception Identification
   - Parent Document: {{DOC_ID}}
   - Failed Item: {{ITEM_ID}}

2. Detailed Description
3. Root Cause
4. Exception Type
5. Proposed Corrective Action

6. Resolution Work
   <!--
   Choose appropriate structure:
   - For test exceptions: TC structure (per TC-TEMPLATE)
   - For CR/INV exceptions: EI table or narrative
   - For simple resolutions: Narrative + evidence
   -->

7. ER Closure
```

**Work estimate:** Minimal. The ER structure is already 80% general. Changes:
1. Relabel two fields (Parent Test Case → Parent Document, Failed Step → Failed Item)
2. Generalize Section 6 header from "Re-test" to "Resolution Work"
3. Add guidance comment explaining structure options
4. Update Exception Type options if needed

Shall I update ER-TEMPLATE to this generalized form?

---

**User:**

Actually, since I'm still treating this idea as experimental, please create the template as TEMPLATE-VAR (VAR for variance). Also, please incorporate the following concept: there are two types of VARs. Type 2 - Pre-approval of the VAR is sufficient to clear the block on the parent. Type 1 - Full closure of the VAR is required to clear the block on the parent.

---

**Claude:**

Created `.claude/workshop/templates/VAR-TEMPLATE.md`

**Key features:**

**VAR Types:**
| Type | Block Cleared When | Use Case |
|------|-------------------|----------|
| Type 1 | Full VAR closure | Critical issues requiring proof of resolution |
| Type 2 | VAR pre-approval | Issues where approved plan is sufficient to proceed |

**Generalized structure:**
```
1. Variance Identification
   - Parent Document (any: CR, INV, TC, TP)
   - Failed Item (EI or Step)
   - VAR Type (1 or 2)

2. Detailed Description
3. Root Cause
4. Variance Type (generalized from Exception Type)
5. Impact Assessment (added back—useful for general variances)
6. Proposed Resolution

7. Resolution Work (flexible structure)
   - TC structure for test-related variances
   - EI table for CR/INV variances
   - Narrative for simple resolutions

8. VAR Closure
9. References
```

**ID hierarchy examples:**
```
CR-005-VAR-001
TP-001-TC-002-VAR-001
INV-003-VAR-001
CR-005-VAR-001-VAR-001 (nested)
```

**Variance Type options (generalized):**
- Execution Error
- Scope Error
- System Error
- Documentation Error
- External Factor
- Other

The Type 1/Type 2 distinction is powerful—it lets the QMS handle both "hard blocks" (must prove fix works) and "soft blocks" (approved plan is enough to proceed in parallel).

---

**User:**

In the VAR-TEMPLATE "TEMPLATE USAGE GUIDE", please explain that Type 2 variances are useful when the resolution of a problem is not deemed critical to "conceptual closure" of the parent artifact and the impacts of the variance are well understood and relatively contained. Type 2 variances are also extremely useful to prevent the dreaded "fell off the radar" problem, i.e., the VAR provides a perfect place to group to-do items that are logically descendant from the parent, but the parent objectives were sufficiently met that it would be inefficient to keep the parent open just for the sake of cleaning up a few stray issues.

---

**Claude:**

Done. Refined wording:

**Type 1:**
> Use when resolution is critical—the parent cannot meaningfully close until the fix is proven to work.

**Type 2:**
> Use when the variance does not affect conceptual closure of the parent. The impacts are well understood and contained, and the parent's core objectives have been met. Type 2 variances also prevent issues from "falling off the radar"—they provide a dedicated container for follow-up work that is logically tied to the parent but would otherwise keep the parent open inefficiently while stray items are cleaned up.

---

**User:**

Now we need to update CR-TEMPLATE to utilize the VAR concept.

---

**Claude:**

Done. CR-TEMPLATE now uses VAR:

**Task Outcome guidance:**
```
TASK OUTCOME:
- Pass: Task completed as planned
- Fail: Task could not be completed as planned — attach VAR with explanation

VAR TYPES (see VAR-TEMPLATE):
- Type 1: Use when the failed task is critical to CR objectives
- Type 2: Use when impact is contained and CR can conceptually close
```

**Execution Comments note:**
```
NOTE: This section is the appropriate place to attach VARs that do not apply
to any individual execution item, but apply to the CR as a whole.
```

Should I also update TC-TEMPLATE and ER-TEMPLATE to reference VAR, or keep ER as the test-specific term while VAR is the generalized concept?

---

**User:**

Add to idea tracker: Just as it is the responsibility of an ER to define its own scope and define its own closure requirements, so too is it the responsibility of the VAR to specify, from the parent EI, what was successfully accomplished in the parent, what the VAR "absorbs", and that no items were lost. If scope truly is reduced, this must be explicitly stated.

---

**Claude:**

Done. Added with the auditor confidence principle:

> **Auditor confidence:** When an auditor sees an EI with an attached VAR, they must have confidence that closure of the VAR is equivalent to complete closure/success of the EI. The VAR is not a loophole—it is a container that fully accounts for the remaining work.

This frames VAR as a tool for rigor, not escape—full accountability transferred, not diffused.

---

**User:**

What remains in our immediate to-do list? Just the CR for SOP updates? Note that, for the purposes of these SOP updates, the VAR is still completely experimental. Also, although we haven't absorbed the templates into the QMS, the concepts they embody should be considered well and truly absorbed into the SOPs. The SOPs should be updated to reflect the intent and concepts that are now contained in the various templates.

---

**Claude:**

Let me summarize what remains:

**SOP Updates Needed (CR required):**

| SOP | Section | Change | Source |
|-----|---------|--------|--------|
| **SOP-004** | §4.2 | EI table structure: Task Description / Execution Summary / Task Outcome / Performed By — Date | CR-TEMPLATE |
| **SOP-004** | §7.1 | Replace PENDING/IN_PROGRESS/COMPLETE/BLOCKED with Pass/Fail binary outcome | CR-TEMPLATE |
| **SOP-004** | §9.1 | Remove "Impact assessment" from ER content requirements | Gap 3 |
| **SOP-004** | §9 (new) | ER owns full re-execution; N/A marking for subsequent steps; nested ERs | TC/ER concepts |
| **SOP-001** | New section | Post-approval gate (4 criteria) for executable document closure | test-exception-concepts.md |

**Concepts to absorb (not VAR—that's experimental):**
- Two-placeholder system (design-time `{{...}}` vs run-time `[...]`)
- EI/Step isomorphism (binary Pass/Fail outcome)
- Execution Comments + Reviewer Comments pattern
- ER as self-contained exception container with full re-execution
- N/A marking when execution pauses after failure
- ID hierarchy (hierarchical document/item/step IDs)

**Explicitly NOT in this CR:**
- VAR concept (experimental)
- Templates themselves (workshop artifacts)

Shall I draft the CR for these SOP updates?

---

**User:**

Sorry, I'm completely changing my mind. I want to officially implement the VAR concept. At this point, VARs and ERs are both used. ERs are used in TCs, VARs are used in all other cases where exception-like possibilities can occur.

---

**Claude:**

Got it. Clear delineation:

| Exception Type | Used In | Context |
|----------------|---------|---------|
| **ER** | TC, TP | Test-specific exceptions |
| **VAR** | CR, INV | Non-test executable documents |

**Updated SOP changes for CR:**

| SOP | Section | Change |
|-----|---------|--------|
| **SOP-004** | §4.2 | EI table: Task Description / Execution Summary / Task Outcome / Performed By |
| **SOP-004** | §7.1 | Status values → Pass/Fail binary |
| **SOP-004** | §9 | ER content (remove Impact Assessment); ER owns full re-execution; N/A marking; nested ERs |
| **SOP-004** | New §10 | VAR concept for non-test exceptions (Type 1/Type 2) |
| **SOP-001** | New section | Post-approval gate (4 criteria) for executable document closure |

**Summary:**
- ER remains test-focused, gains the full re-execution/nesting concepts
- VAR is the generalized exception container for CR/INV
- Both share similar structure but serve different domains

Shall I draft the CR now?

---

**User:**

Shouldn't SOP-002, the change control SOP, be updated to account for the VAR concept, which applies to CRs?

---

**Claude:**

You're right. Let me think through the SOP ownership:

| SOP | Focus | Exception Concept |
|-----|-------|-------------------|
| SOP-001 | Document Control | Closure requirements (post-approval gate) |
| SOP-002 | Change Control (CRs) | **VAR for CR exceptions** |
| SOP-003 | Deviation Management (INVs) | VAR for INV exceptions? |
| SOP-004 | Document Execution (all) | General mechanics; ER for test exceptions |

**Options:**

**A. SOP-004 defines both ER and VAR (umbrella)**
- SOP-004 owns all exception concepts
- SOP-002 references SOP-004 for VAR in CR context
- Keeps exception handling in one place

**B. Split by document type**
- SOP-002 defines VAR for CRs
- SOP-003 defines VAR for INVs (or references SOP-002)
- SOP-004 defines ER for test documents
- More aligned with "each SOP owns its domain"

**My recommendation:** Option A—SOP-004 defines both ER and VAR since it's already the execution SOP for all executable documents. SOP-002 then references SOP-004 for CR execution details, including VAR.

But SOP-002 should at minimum mention that CRs use VAR for execution exceptions per SOP-004.

What's your preference?

---

**User:**

Option A! Please draft the CR.

---

**User:**

python .claude/qms.py --user claude create CR --title "SOP Updates: Execution Mechanics, ER/VAR Exception Handling, and Closure Requirements"

---

**User:**

This session is being continued from a previous conversation that ran out of context. The conversation is summarized below:
Analysis:
Let me chronologically analyze the conversation:

1. **Session Start**: User asked to read CLAUDE.md, notes from recent sessions, idea tracker, workshop contents, previous session chronicle, and Recursive Governance Loop document. I read all these files and established Session-2026-01-06-002.

2. **CR Template Review**: User wanted to look at the CR template together. We discussed the two-placeholder system (`{{template}}` vs `[execution]`).

3. **TC Template Development**: User noted this pattern applies to test protocols, forms, etc. User revealed they work as an automation engineer at Merck (pharma) in Durham, NC. We started with TC (Test Case) as the most fundamental executable document fragment.

4. **TC Template Iterations**:
   - Started with Prerequisite Section, Test Script, Comments
   - User requested single row for prerequisite with signature as final column
   - User requested single multi-row table for test script instead of separate tables per step
   - User requested step ID format: `{{TEST_CASE_ID}}-001`, etc.
   - User requested "Performed By" terminology instead of "Executed By"
   - Added boilerplate: signature attestation and acceptance criteria
   - Moved acceptance criteria under Test Script section
   - User asked me to improve Merck's wordy acceptance criteria
   - Added Instructions section referencing SOP-004
   - Added REQ ID column to test script, removed Requirements Coverage from TP

5. **Test Exception Concepts**: Created notes file with provisional wording about exceptions, pass/fail rules, re-testing within ER, nested ERs, expanded acceptance criteria.

6. **TP Template Development**: Created wrapper template with Purpose, Scope, Test Cases (referencing TC-TEMPLATE), Protocol Summary, References. User provided feedback:
   - Remove workflow signatures (handled by QMS CLI)
   - Use template nesting (reference TC-TEMPLATE, don't duplicate)
   - Remove Test Environment section
   - Remove Test Case Results table
   - Move References to end
   - Remove Out of Scope section

7. **Re-execution Discussion**: User asked how to handle re-execution. Decision: ER owns re-execution end-to-end, TC shows original only, full re-execution in ER (not just failed step because test script itself might be defective).

8. **ER Template Development**: Created ER template with Exception Identification, Detailed Description, Root Cause, Exception Type, Proposed Corrective Action, Re-test section (full TC), ER Closure.

9. **Consistency Analysis**: Reviewed all four templates against test-exception-concepts.md and SOP-004. Identified 6 gaps:
   - Gap 1: CR comment table format differs
   - Gap 2: CR status values differ from SOP-004
   - Gap 3: ER missing Impact Assessment
   - Gap 4: "Pass with exception" not in TC Acceptance Criteria
   - Gap 5: ID hierarchy not in TC/TP
   - Gap 6: Post-approval gate not in templates

10. **Template Changes** (no CR needed):
    - Fixed Gap 1: Updated CR comment table format
    - Fixed Gap 5: Added ID hierarchy to TC and TP templates
    - Gap 2 resolved by restructuring CR EI table

11. **CR Template Restructure**: User noted EI/TC step isomorphism. New structure:
    - Task Description (static)
    - Execution Summary (narrative, editable)
    - Task Outcome (Pass/Fail, editable)
    - Performed By — Date
    - Added Execution Comments and Reviewer Comments sections

12. **VAR Concept Introduction**: User proposed generalizing ERs as "links" between executable documents. Created VAR-TEMPLATE (Variance Report) with:
    - Type 1: Full closure required to clear block
    - Type 2: Pre-approval sufficient to clear block
    - Generalized structure for any executable document

13. **Updates for VAR**:
    - Updated CR-TEMPLATE to use VAR instead of ER
    - Added idea to tracker about VAR scope handoff requirements

14. **Final Decision**: User decided ERs for TCs, VARs for all other cases. Wants to draft CR for SOP updates.

15. **CR-014 Creation**: Created CR-014 for SOP updates. Attempted to write to workspace file but got error (file not read first).

Summary:
1. Primary Request and Intent:
   - Start session by reading all relevant context documents (CLAUDE.md, notes, SOPs, chronicles, etc.)
   - Develop executable document templates using a two-placeholder system (`{{design-time}}` vs `[run-time]`)
   - Create TC-TEMPLATE (Test Case) as atomic testable unit based on Merck pharma patterns
   - Create TP-TEMPLATE (Test Protocol) as wrapper for TCs
   - Create ER-TEMPLATE (Exception Report) for test-specific exceptions with full re-execution
   - Create VAR-TEMPLATE (Variance Report) as generalized exception container for non-test documents
   - Update CR-TEMPLATE to use isomorphic EI/step structure with Pass/Fail outcome
   - Draft CR-014 to update SOPs (SOP-001, SOP-002, SOP-004) with new execution mechanics and exception handling concepts

2. Key Technical Concepts:
   - Two-placeholder system: `{{template}}` for design-time, `[execution]` for run-time
   - EI/Test Step isomorphism: CR execution items structurally identical to TC test steps
   - Binary Pass/Fail outcome replacing PENDING/IN_PROGRESS/COMPLETE/BLOCKED
   - ER owns full re-execution (not just failed step) because test script itself might be defective
   - N/A marking for subsequent steps after test failure
   - Nested exception handling (ER-in-ER, VAR-in-VAR)
   - Template nesting (TP references TC-TEMPLATE, ER embeds TC structure)
   - VAR Type 1 vs Type 2: Full closure required vs pre-approval sufficient
   - ID hierarchy: TP-NNN-TC-NNN-NNN (step), TP-NNN-TC-NNN-ER-NNN (exception)
   - "Performed By — Date" signature format
   - Test Execution Comments + Reviewer Comments pattern

3. Files and Code Sections:

   - `.claude/workshop/templates/TC-TEMPLATE.md` (Created and refined)
     - Atomic test case fragment that composes into TPs
     - Final structure includes Prerequisite Section, Test Script with REQ ID column, Comments
     ```markdown
     | Step | REQ ID | Instruction | Expected Result | Actual Result | Pass/Fail | Performed By — Date |
     |------|--------|-------------|-----------------|---------------|-----------|---------------------|
     | {{TEST_CASE_ID}}-001 | {{REQ_ID}} | {{INSTRUCTION}} | {{EXPECTED}} | [ACTUAL] | [Pass/Fail] | [PERFORMER] — [DATE] |
     ```

   - `.claude/workshop/templates/TP-TEMPLATE.md` (Created and refined)
     - Protocol wrapper with Purpose, Scope (System/Version/Commit), Test Cases (reference TC-TEMPLATE), Protocol Summary, References
     - ID hierarchy documented in usage guide

   - `.claude/workshop/templates/ER-TEMPLATE.md` (Created)
     - Test-specific exception handling
     - Contains full TC re-execution structure
     - Exception types: Test Script Error, Test Execution Error, System Error, Documentation Error, Other

   - `.claude/workshop/templates/VAR-TEMPLATE.md` (Created)
     - Generalized exception container for non-test documents
     - Type 1 (critical) vs Type 2 (contained impact, prevents "fell off radar")
     ```markdown
     Type 1: Use when resolution is critical—the parent cannot meaningfully
     close until the fix is proven to work.
     
     Type 2: Use when the variance does not affect conceptual closure of the
     parent. The impacts are well understood and contained...
     ```

   - `.claude/workshop/templates/CR-TEMPLATE.md` (Major updates)
     - Restructured EI table to match TC step structure
     - Now uses VAR for exception handling
     ```markdown
     | EI | Task Description | Execution Summary | Task Outcome | Performed By — Date |
     |----|------------------|-------------------|--------------|---------------------|
     | EI-1 | {{DESCRIPTION}} | [SUMMARY] | [Pass/Fail] | [PERFORMER] — [DATE] |
     ```

   - `.claude/notes/Session-2026-01-06-002/test-exception-concepts.md` (Created)
     - Provisional wording for pass/fail rules, re-testing, nested ERs, closure requirements

   - `.claude/TO_DO_LIST.md` (Created)
     - First item: Handle "pass with exception" scenario

   - `.claude/notes/IDEA_TRACKER.md` (Updated)
     - Added GMP signature/timestamp format idea
     - Added VAR scope handoff requirements

4. Errors and fixes:
   - User rejected my verbatim copy of their wording for VAR Type 2 description, asked me to improve clarity. I rewrote it more concisely.
   - User rejected my first attempt at concise Acceptance Criteria ("too concise"), I found middle ground.
   - File write error on CR-014 workspace file: "File has not been read yet. Read it first before writing to it." - Need to read file first.

5. Problem Solving:
   - Resolved Gap 2 (CR status values) by restructuring EI table to use Pass/Fail instead of status values
   - Unified CR and TC execution patterns through isomorphism insight
   - Generalized ER concept into VAR for non-test contexts
   - Deferred "pass with exception" scenario to TO_DO_LIST

6. All user messages:
   - "Let's look at the CR template together."
   - "Yes, let's sketch out the TP template. The TP can be considered the most fundamental of the executable documents... Have I mentioned to you what my job is, btw?"
   - "We can streamline Merck's pattern a bit. The prerequisite section can be a single row..."
   - "The entire test script should be a multi-row table, with one row per step, and signature in the final column."
   - "The test script's 'Step' column should not use a simple integer format, but should be in the format {{TEST_CASE_ID}}-001..."
   - "For the Pass/Fail column, please actually write [Pass/Fail] instead of [P/F]. Also... use the terminology 'Performed By' instead of 'Executed By'."
   - "Please used PERFORMER there as well"
   - "Let's add some more boilerplate content..." (signature attestation, acceptance criteria)
   - "Actually, please move the Acceptance Criteria statement to just above the Test Script table..."
   - "I must admit that the official Merck statement for Acceptance Criteria is wordy. Can you rephrase it..."
   - "Above Acceptance Criteria, please write Instructions..." (SOP-004 reference, failure handling)
   - "Is the current version of our draft TC-TEMPLATE up-to-date?"
   - "Now sketch out the TP template wrapper"
   - Multiple feedback items on TP template (remove signatures, use nesting, remove sections)
   - "Let's return to the TC template. We need to think about how we're going to deal with re-execution..."
   - "Let's go the purist route: ER owns the exception end-to-end, including retesting inside the ER..."
   - "Add to idea tracker: GMP conventions for signature and timestamp formats..."
   - "Sketch out the ER template now"
   - "Let's strive for minimal information duplication..." (refined ER template structure)
   - Exception Type definitions
   - Re-test instructions addition about modified test scripts
   - Note about Test Execution Comments being place for protocol-level ERs
   - "Review all four templates side-by-side..." (consistency analysis request)
   - "Gap 3 - We will update SOP-004 to remove the impact assessment requirement..." (gap resolution decisions)
   - "Please create a document TO_DO_LIST.md..."
   - "Next, please implement all of the template-related changes (no CR needed)"
   - "Let's discuss Gap 2 a bit further..." (EI/TC isomorphism insight)
   - "In the CR EI table, please add a column between Task Description and Task Outcome called Execution Summary..."
   - "I'm thinking that we can begin to think of ERs as 'links' between executable documents..." (VAR concept)
   - "Actually, since I'm still treating this idea as experimental, please create the template as TEMPLATE-VAR..."
   - Type 1/Type 2 VAR explanation
   - "Now we need to update CR-TEMPLATE to utilize the VAR concept."
   - "Add to idea tracker: Just as it is the responsibility of an ER to define its own scope..."
   - "What remains in our immediate to-do list?..."
   - "Shouldn't SOP-002, the change control SOP, be updated to account for the VAR concept..."
   - "Option A! Please draft the CR."
   - "Sorry, I'm completely changing my mind. I want to officially implement the VAR concept. At this point, VARs and ERs are both used. ERs are used in TCs, VARs are used in all other cases..."

7. Pending Tasks:
   - Complete CR-014 draft (fix file write error)
   - Check in CR-014 and route for review
   - Execute CR-014 (update SOP-001, SOP-002, SOP-004)

8. Current Work:
   Drafting CR-014 for SOP updates. Created CR-014 via QMS CLI, attempted to write content to workspace file but encountered error "File has not been read yet. Read it first before writing to it."

   The CR-014 content was prepared with:
   - Purpose: Update SOPs with execution mechanics, ER/VAR exception handling, closure requirements
   - Scope: SOP-004 (major), SOP-002 (VAR reference), SOP-001 (closure gate)
   - 6 Execution Items covering each SOP section update
   - Uses new CR template format with EI/Task Description/Execution Summary/Task Outcome/Performed By

9. Optional Next Step:
   Read the workspace file first, then write CR-014 content:
   ```
   User: "Option A! Please draft the CR."
   ```
   I created CR-014 and need to complete writing its content after reading the file first to avoid the error..
Please continue the conversation from where we left it off without asking the user any further questions. Continue with the last task that you were asked to work on.

---

**Claude:**

Continuing with CR-014 drafting. I need to read the workspace file first before writing to it.

---

**Claude:**

Let me check what's in the workspace and the current status of CR-014:

---

**User:**

python .claude/qms.py --user claude status CR-014

---

**Claude:**

Good, CR-014 exists and is checked out. Let me find the draft file:

---

**Claude:**

Now I have context on all SOPs. Let me write the CR-014 content using the new template format:

---

**Claude:**

CR-014 has been drafted and routed for pre-review. Let me spawn QA to review it:

---

**Claude:**

QA has requested updates. Let me address the deficiencies:

---

**Claude:**

Let me address QA's deficiencies by updating the CR:

---

**Claude:**

CR-014 is now in execution. Let me execute the EIs by updating the SOPs. I'll start with SOP-004:

---

**Claude:**

Let me make the SOP-004 updates. Starting with EI-1 (Section 4.2):

---

**Claude:**

All three SOPs are routed for review. Let me spawn QA to review them:

---

**Claude:**

All SOPs are reviewed. Let me route them for approval:

---

**Claude:**

All SOPs are now EFFECTIVE. Now I need to document the execution in CR-014 and complete the workflow:

---

**Claude:**

**CR-014 Complete**

The CR for SOP updates has been successfully executed and closed. Here's what was accomplished:

## Summary

**CR-014:** SOP Updates: Execution Mechanics, ER/VAR Exception Handling, and Closure Requirements

### Documents Updated

| Document | Version | Key Changes |
|----------|---------|-------------|
| **SOP-004** | v2.0 | Pass/Fail outcomes, VAR framework (Type 1/Type 2), updated ER scope, strengthened closure gates |
| **SOP-002** | v5.0 | VAR reference in post-review requirements |
| **SOP-001** | v11.0 | VAR in scope, definitions, and naming conventions |

### Key Concepts Now Formalized

1. **Binary Execution Outcomes:** EIs now use Pass/Fail instead of PENDING/IN_PROGRESS/COMPLETE/BLOCKED
2. **ER vs VAR Distinction:** ERs for test failures (TC/TP), VARs for non-test executables (CR/INV)
3. **VAR Type 1/Type 2:** Type 1 requires full closure; Type 2 allows pre-approval to clear parent block
4. **Strengthened Closure Gates:** All EIs must Pass or have documented exception (VAR/ER)

The session from which these concepts originated (Session-2026-01-06-002) developed the template framework that informed these SOP updates.

---

**User:**

Please add this to the to-do list: Create "/idea" and "/todo" slash commands.

---

**Claude:**

Added to the to-do list:
- **Create /idea and /todo slash commands** (pending)

This aligns with the idea from the tracker about making `/idea` expand to append entries to IDEA_TRACKER.md with timestamps. Would you like me to start working on these now, or is there something else you'd like to address first?

---

**User:**

Also add to the to-do list: Remove the "Reviewed By" execution block from all templates. I realized this is overkill when the whole document will go through a review process already.

---

**Claude:**

Added. Current to-do list:

1. **Create /idea and /todo slash commands** (pending)
2. **Remove Reviewer Comments section from all templates** (pending) — redundant with document review process

---

**User:**

New idea: make the executed parts of a document more visually distinguishable. Now, when I look at a post-approved and closed CR, I can't immediately tell, at a glance, what the executed parts were, without having some deeper knowledge of what the document structure / template was.

---

**Claude:**

Added to the idea tracker with some possible solutions I brainstormed:

1. **Section headers with visual markers** — e.g., `## 6. Execution ▶ COMPLETED`
2. **Blockquote/callout wrapping** — GitHub-style `> [!EXECUTED]`
3. **Horizontal rule boundaries** — double `---` or ASCII separators
4. **Background shading** — HTML divs (renderer-dependent)
5. **Prefix/suffix markers** — `[EXECUTION START]` / `[EXECUTION END]`

Key constraint: must work in raw markdown since agents read raw, but should also render meaningfully in GitHub views.

---

**User:**

Let's create the /idea slash command

---

**Claude:**

Created `.claude/commands/idea.md`. Let me test it:

---

**Claude:**

The command is created, but custom slash commands are invoked directly by you (the user), not via the Skill tool I use. The `/idea` command is now available for you to use like:

```
/idea Add caching layer for QMS metadata lookups
```

Let me verify the file is properly formatted:

---

**Claude:**

The `/idea` command is ready. Now let me create the `/todo` command:

---

**Claude:**

Done! Both slash commands are now available:

**`/idea <description>`** → Adds to `.claude/notes/IDEA_TRACKER.md`
**`/todo <task>`** → Adds to `.claude/TO_DO_LIST.md`

Files created:
- `.claude/commands/idea.md`
- `.claude/commands/todo.md`

You can try them now. Note: The TO_DO_LIST.md file doesn't exist yet, but the command will create it on first use.

---

**User:**

The TO_DO_LIST.md file does already exist, just so you know!

---

**Claude:**

You're right! I actually created it earlier in this session (from the context summary) with the "pass with exception" scenario item. Good to have the `/todo` command ready to add more items to it now.

---

**User:**

Please move the to-do list item about "Remove Reviewer Comments (etc...)" to TO_DO_LIST.md, and you can cross it off the Claude Code session's build-in checklist tracker thingy

---

**Claude:**

Done. Moved to `TO_DO_LIST.md` and cleared the session tracker.

---

**User:**

This was one of the most productive sessions I've had with you! Please produce a comprehensive summary and add it to this session's notes folder.

---

**Claude:**

Got it! Session summary created at:

`.claude/notes/Session-2026-01-06-002/SESSION-SUMMARY.md`

The summary covers:
- **CR-014** execution and closure (3 SOPs updated)
- **Template design patterns** (two-placeholder system, EI/TC isomorphism)
- **VAR framework** (Type 1/Type 2 distinction, VAR vs ER vs INV)
- **Slash commands** (`/idea`, `/todo`)
- **Ideas and to-do items** captured
- **Session statistics** and continuation notes

---

**User:**

Please commit and push

---

**Claude:**

Done! Committed and pushed:

```
e458281 CR-014: SOP Execution Mechanics Overhaul
 33 files changed, 5355 insertions(+), 94 deletions(-)
```

Key artifacts pushed:
- **3 SOPs** updated (SOP-001 v11.0, SOP-002 v5.0, SOP-004 v2.0)
- **CR-014** complete with archives
- **4 workshop templates** (CR, TP, TC, VAR)
- **2 slash commands** (`/idea`, `/todo`)
- **Session summary** and notes

---

**User:**

Can you please study the session end hook chronicle capture Python script? I'm worried that since you manually created the index for the current session, that script might crash. But I'm not sure. I can't remember if that script creates the index or not, and if not, whether it will crash or be otherwise confused (like get the numbering wrong) when I end this session and the hook runs.

---

**Claude:**

Good catch! I see the issue. Here's my analysis:

## How the Script Works

1. **`get_next_session_number()` (lines 29-45):** Scans the chronicles directory for existing `Session-YYYY-MM-DD-NNN.md` **files** and returns max + 1

2. **Index Update (lines 199-212):** Simply **appends** the new entry to INDEX.md without checking for duplicates

## The Problem

I added this line to INDEX.md:
```markdown
- [Session-2026-01-06-002](Session-2026-01-06-002.md)
```

But the actual chronicle **file** `Session-2026-01-06-002.md` doesn't exist yet (you rejected my attempt to create it, correctly noting chronicles are auto-generated).

When the hook runs:
1. It will scan for `Session-2026-01-06-*.md` files
2. It will only find `Session-2026-01-06-001.md`
3. It will correctly create `Session-2026-01-06-002.md` ✓
4. It will **append** a duplicate entry to INDEX.md ✗

## The Fix

I should remove the INDEX.md entry I added:

---

**Claude:**

Fixed. Now I should amend the commit to include this correction:

---

**Claude:**

`git push --force-with-lease` force-pushes your local branch to the remote, but with a safety check: it only succeeds if the remote branch hasn't been updated by someone else since you last fetched.

**Why it's needed here:**
- I already pushed commit `e458281` to remote
- Then I amended it (changed the INDEX.md fix), creating a new commit `c0d7b25`
- The remote still has `e458281`, but my local now has `c0d7b25`
- A normal `git push` would fail because the histories diverged
- Force push replaces the remote commit with my amended one

**The risk:** If someone else had pushed to main in between, force push would overwrite their work. `--force-with-lease` prevents that by checking first.

**Alternative:** We could just make a new commit with the INDEX.md fix instead of amending:

---

**Claude:**

Done. The amended commit is now on remote. The hook will correctly add Session-2026-01-06-002 to the INDEX when this session ends.


*End of Chronicle - 2026-01-06 21:17*
